Moreover, SHP2 is an important mediator in lupus erythematosus, ERK/MAPK signaling normalization and reduced production of IFN-γ and IL-17a cytokines involved in inflammation can occur by directly inhibiting SHP2 (Wang et al., 2016). Here, IL17A is linked to lupus erythematosus.